Fluorescence polarization—based diagnostic assay for equine infectious anemia virus
US6350574B1 · kind B1 · utility
3Cited by
5References
22Claims
0Family size
Inventors
Key dates
| Filing date | Sep 21, 1999 |
| Grant date | Feb 26, 2002 |
| Priority date | — |
| Expiry date | Sep 21, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/968
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A fluorescence polarization assay for Equine Infectious Anemia Virus utilizes a short peptide reagent probe derived from a conserved immunodominant region of gp45. The probe is N-terminally labeled, preferably with 6-carboxyfluorescein, and purified by HPLC, which reacts in a homogenous assay with anti-EIAV antibodies contained in the serum of field infected horses and ponies. The assay has a sensitivity of about 90 percent with a specificity approaching 100 percent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.